[1] Kristiansen K,Hagen S,Kollevold T,et al.Combined modality therapy of operated astrocytomas grade Ⅲ and Ⅳ confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Study Group[J].Cancer,1981,47(4):649-652.
[2] Garcia DM,Fulling KH,Marks JE.The value of radiation therapy in addition to surgery for astrocytomas of the adult cerebrum[J].Cancer,1985,55(5):919-927.
[3] Stupp R,Mason WP,van den Bent MJ,et al.Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma[J]. N Engl J Med,2005,352(10):987-996.
[4] Kelly PJ,Daumas-Duport C,Scheithauer BW,et al.Stereotactic histologic correlations of computed tomography and magnetic resonance imaging-defined abnormalities in patients with glial neoplasms[J]. Mayo Clin Proc,1987,62(6):450-459.
[5] Bakir A,Gezen F,Yildiz O,et al. Establishment and characterization of a human glioblastoma multiforme cell line[J]. Cancer Genet Cytogenet,1998,103(1):46-51.
[6] Qu J,Rizak JD,Fan Y,et al.Establishment and partial characterization of a human tumor cell line,GBM-HSF,from a glioblastoma multiforme[J].Hum Cell,2014,27(3):129-136.
[7] Coffey JC,Wang JH,Smith MJ,et al.Excisional surgery for cancer cure: therapy at a cost[J]. Lancet Oncol,2003,4(12):760-768.
[8] Demicheli R,Valagussa P,Bonadonna G.Does surgery modify growth kinetics of breast cancer micrometastases?[J]. Br J Cancer,2001,85(4):490-492.
[9] Do V,Gebski V,Barton MB.The effect of waiting for radiotherapy for grade Ⅲ/Ⅳ gliomas[J].Radiother Oncol,2000,57(2):131-136.
[10] Irwin C,Hunn M,Purdie G,et al.Delay in radiotherapy shortens survival in patients with high grade glioma[J].J Neurooncol,2007,85(3):339-343.
[11] Noel G,Huchet A,Feuvret L,et al.Waiting times before initiation of radiotherapy might not affect outcomes for patients with Glioblastoma: a French retrospective analysis of patients treated in the era of concomitant temozolomide and radiotherapy[J]. J Neurooncol, 2012, 109(1): 167-175.. DOI:10.1007/s11060-012-0883-7.
[12] Blumenthal DT,Won M,Mehta MP,et al.Short delay in initiation of radiotherapy may not affect outcome of patients with glioblastoma: a secondary analysis from the radiation therapy oncology group database[J].J Clin Oncol,2009,27(5):733-739. DOI:10.1200/JCO.2008.18.9035.
[13] Lawrence YR,Blumenthal DT,Matceyevsky D,et al.Delayed initiation of radiotherapy for glioblastoma:how important is it to push to the front(or the back)of the line?[J].J Neurooncol,2011,105(1):1-7. DOI:10.1007/s11060-011-0589-2.
[14] Keime-Guibert F,Chinot O,Taillandier L,et al.Radiotherapy for glioblastoma in the elderly[J]. N Engl J Med,2007,356(15):1527-1535.
[15] Roa W,Brasher PM,Bauman G,et al.Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial[J].J Clin Oncol,2004,22(9):1583-1588.
[16] Lai R,Hershman DL,Doan T,et al.The timing of cranial radiation in elderly patients with newly diagnosed glioblastoma multiforme[J]. Neuro Oncol,2010,12(2):190-198. DOI:10.1093/neuonc/nop004.
[17] Wallner KE,Galicich JH,Krol G,et al.Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma[J].Int J Radiat Oncol Biol Phys,1989,16(6):1405-1409.
[18] Garden AS,Maor MH,Yung WK,et al.Outcome and patterns of failure following limited-volume irradiation for malignant astrocytomas[J].Radiother Oncol,1991,20(2):99-110.
[19] Gaspar LE,Fisher BJ,Macdonald DR,et al.Supratentorial malignant glioma: Patterns of recurrence and implications for external beam local treatment[J].Int J Radiat Oncol Biol Phy,1992,24(1):55-57.
[20] Sneed PK,Gutin PH,Larson DA,et alPatterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost[J].Int J Radiat Oncol Biol Phys,1994,29(4):719-727.
[21] Minniti G,Amelio D,Amichetti M,et al.Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide[J].Radiother Oncol,2010,97(3):377-381. DOI:10.1016/j.radonc.2010.08.020.
[22] Weber DC,Casanova N,Zilli T,et al.Recurrence pattern after[(18)F]fluoroethyltyrosine-positron emission tomography-guided radiotherapy for high-grade glioma:a prospective study[J].Radiother Oncol,2009,93(3):586-592. DOI:10.1016/j.radonc.2009.08.043.
[23] McDonald MW,Shu HK,Curran WJ,et al.Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma[J]. Int J Radiat Oncol Biol Phys,2011,79(1):130-136. DOI:10.1016/j.ijrobp.2011.04.023.
[24] Ove R,Cavalieri R,Noble D,et al.Variation of neck position with image-guided radiotherapy for head and neck cancer[J].Am J Clin Oncol,2012,35(1):1-5. DOI:10.1097/COC.0b013e3181fe46bb.
[25] Fiorentino A,Caivano R,Pedicini P,et al.Clinical target volume definition for glioblastoma radiotherapy planning:magnetic resonance imaging and computed tomography[J].Clin Transl Oncol,2013,15(9):754-758. DOI:10.1007/s12094-012-0992-y.
[26] 蒋马伟,周仁华,姚原,等. 脑胶质瘤放疗靶区确定的方法学研究[J].中华肿瘤防治杂志,2007,14(13):997-999.
[27] Baumann M,DuBois W,Pu A,et al.Response of xenografts of human malignant gliomas and squamous cell carcinomas to fractionated irradiation[J].Int J Radiat Oncol Biol Phys, 1992,23(4):803-809.
[28] Baumann M,Krause M,Thames H,et al.Cancer stem cells and radiotherapy[J].Int J Radiat Biol,2009,85(5):391-402. DOI:10.1080/09553000902836404.
[29] Chang CH,Horton J,Schoenfeld D,et al.Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas.A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study[J].Cancer,1983,52(6):997-1007.
[30] Bleehen NM,Stenning SP.A medical research council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma.The medical research council brain tumour working party[J].Br J Cancer,1991,64(4):769-774.
[31] Stupp R,Tonn,JC,Brada M,et al.High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis,treatment and follow-up[J]. Ann Oncol,2010,21(Suppl 5):190-193. DOI:10.1093/annonc/mdq187.
[32] Nakagawa K,Aoki Y,Fujimaki T,et al.High-dose conformal radiotherapy influenced the pattern of failure but did not improve survival in glioblastoma multiforme[J].Int J Radiat Oncol Biol Phys,1998,40(5):1141-1149.
[33] Chan JL,Lee SW,Fraass BA,et al.Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy[J].J Clin Oncol,2002,20(6):1635-1642.
[34] Graf R,Hildebrandt B,Tilly W,et al. Dose-escalated conformal radiotherapy of glioblastomas: results of a retrospective comparison applying radiation doses of 60 and 70 Gy[J].Onkologie,2005,28(6-7):325-330.
[35] Watkins JM,Marshall DT,Patel S,et al. High-dose radiotherapy to 78 Gy with or without temozolomide for high grade gliomas[J].J Neurooncol,2009,93(3):343-348. DOI:10.1007/s11060-008-9779-y.
[36] Tsien C,Moughan J,Michalski JM,et al.Phase I three-dimensional conformal radiation dose escalation study in newly diagnosed glioblastoma:radiation therapy oncology group trial 98-03[J].Int J Radiat Oncol Biol Phys,2009,73(3):699-708. DOI:10.1016/j.ijrobp.2008.05.034.
[37] Monjazeb AM,Ayala D,Jensen C,et al.A phase dose escalation study of hypofractionated IMRT field-in field boost for newly diagnosed glioblastoma multiforme[J].Int J Radiat Oncol Biol Phys,2012,82(2):743-748. DOI:10.1016/j.ijrobp.2010.10.018.
[38] Coughlin C,Scott C,Langer C,et al. Phase Ⅱ,two-arm RTOG trial(94-11) of bischloroethyl-nitrosourea plus accelerated hyperfractionated radiotherapy(64.0 or 70.4 Gy) based on tumor volume(>20 or
[39] Souhami L,Seiferheld W,Brachman D,et al.Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme:report of radiation therapy oncology group 93-05 protocol[J].Int J Radiat Oncol Biol Phys,2004,60(3):853-860.
[40] Tsien CI,Brown D,Normolle D,et al.Concurrent temozolomide and dose-escalated intensity-modulated radiation therapy in newly diagnosed glioblastoma[J].Clin Cancer Res,2012,18(1):273-279. DOI:10.1158/1078-0432.CCR-11-2073.
[41] Takano S,Ishikawa E,Nakai K,et al.Bevacizumab in Japanese patients with malignant glioma: from basic research to clinical trial[J].Oncol Targets Ther,2014,7:1551-1562. DOI:10.2147/OTT.S67621.
[42] Myra E,Van Linde,Joost JC,et al.Bevacizumab in combination with radiotherapy and temozolomide for patients with newly diagnosed glioblastoma multiforme[J]. Oncologist,2015,20(2):107-108. DOI:10.1634/theoncologist.2014-0418.
[43] Ney DE,Carlson JA,Damek DM,et al.Phase Ⅱ trial of hypofractionated intensity-modulated radiation therapy combined with temozolomide and bevacizumab for patients with newly diagnosed glioblastoma[J].J Neurooncol,2015,122(1):135-143. DOI:10.1007/s11060-014-1691-z.
[44] Gilbert MR,Dignam JJ,Armstrong TS,et al.A randomized trial of bevacizumab for newly diagnosed glioblastoma[J].N Engl J Med,2014,370(8):699-708. DOI:10.1056/NEJMoa1308573.
2015, Vol. 24 
